Select Page

News & events

World Economic Forum – Dr. Etienne de Villers-Sidani speaks in Tianjin, China

Sep 18, 2018 | News

Dr. de Villers-Sidani was amongst the three McGill researchers presented their work to the World Economic Forum’s (WEF) Annual Meeting of the New Champions (a.k.a. “Summer Davos”) on September 18, in Tianjin, China. It’s the foremost global summit on innovation, science and technology, promoting entrepreneurship in the global public interest.

The World Economic Forum (WEF) has been shaping the future of business and society, bringing together leaders from major multinationals, government, media, academia and civil society, since 2007.

“I have been working on improving communication for those who cannot adequately communicate because of neurological diseases such as amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s Disease,” says Dr. de Villers-Sidani.  “Eye movements remain largely intact in most neurological and medical conditions, thus making communication with these individuals possible. We are working on developing an app that works with any mobile device (tablet, smartphone) equipped with a camera. Using our eye-tracking technology, patients can control a cursor on their device using only their eye movements, allowing them to rapidly communicate with others by selecting pre-defined sentences and words on the screen. Science in the service of the public is a way for us to give back to improve quality of life for patients.”

You can find the news on McGill Reporter here, and the video of Etienne speaking here.


Innodem launches Pigio™ on the App store

Innodem launches Pigio™ on the App store

Patients who have lost the use of speech will soon be able to communicate with their eyes thanks to a mobile application developed in Quebec. Called Pigio™, the application will allow communication with the eyes, which act as a cursor on a digital screen. "You have...

Innodem raises $1M in angel financing

Innodem raises $1M in angel financing

Montreal-based Innodem Neurosciences has received $1 million from angel, banking, and government entities to begin commercializing Pigio™, its first mobile app. Pigio™ uses AI-powered mobile software technology to allow paralyzed or intubated patients to communicate...